Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self-Controlled Case Series Study

被引:0
作者
Szilcz, Mate [1 ]
Wastesson, Jonas W. [1 ,2 ,3 ]
Bergman, David [1 ]
Johnell, Kristina [1 ]
Ludvigsson, Jonas F. [1 ,4 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[2] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Society, Stockholm, Sweden
[3] Stockholm Univ, Stockholm, Sweden
[4] Orebro Univ Hosp, Dept Paediat, Orebro, Sweden
[5] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA
基金
瑞典研究理事会;
关键词
antibiotics; microscopic colitis; pharmacoepidemiology; NORMAL GASTROINTESTINAL MUCOSA; POPULATION; EPIDEMIOLOGY; REGISTER; BIOPSY;
D O I
10.1111/apt.70028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundSeveral drugs have been linked to the risk of microscopic colitis (MC), a condition characterised by watery, non-bloody diarrhoea. Antibiotics can induce similar symptoms, but their connection to MC remains unclear.AimTo investigate the antibiotic-related risks of MC in adults aged 65 years and older.MethodsThis was a nationwide, self-controlled case series study including adults aged >= 65 years with a new prescription for antibiotics and biopsy-confirmed, incident MC (Sweden, 2007-17). We identified cases from the nationwide histopathology cohort ESPRESSO individually linked to several registers. Using conditional Poisson regression, we estimated incidence rate ratios (IRR) for four risk periods: on treatment, and 1-14, 15-91, and 92-365 days post-treatment, compared with the non-treatment periods in the same individual. We also conducted a negative control outcome analysis to assess whether the association was specific to MC or due to diagnostic workup. E-values were used to assess robustness to unmeasured confounding.ResultsWe identified 2393 persons with incident biopsy-confirmed MC (median age at diagnosis 74; 67% women). Compared with the non-treatment periods, the risk of MC in the age-adjusted analysis increased with antibiotic treatment (IRR: 1.44 [95% CI: 1.13-1.84], E-value: 2.24), 1-14 days (IRR: 1.12 [0.83-1.49]), 15-91 days (1.12 [0.97-1.31]) and 92-365 days post-treatment (1.19 [1.07-1.32]). The negative control outcome analysis showed similar risks of biopsy-confirmed normal mucosa after antibiotic use.ConclusionThe observed association between antibiotic use and MC may result from detection bias rather than a causal relationship.
引用
收藏
页码:1500 / 1507
页数:8
相关论文
共 49 条
  • [41] Sensitivity Analysis in Observational Research: Introducing the E-Value
    VanderWeele, Tyler J.
    Ding, Peng
    [J]. ANNALS OF INTERNAL MEDICINE, 2017, 167 (04) : 268 - +
  • [42] Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
    Vila, Arnau Vich
    Collij, Valerie
    Sanna, Serena
    Sinha, Trishla
    Imhann, Floris
    Bourgonje, Arno R.
    Mujagic, Zlatan
    Jonkers, Daisy M. A. E.
    Masclee, Ad A. M.
    Fu, Jingyuan
    Kurilshikov, Alexander
    Wijmenga, Cisca
    Zhernakova, Alexandra
    Weersma, Rinse K.
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [43] The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific Literature
    Wallerstedt, Susanna M.
    Wettermark, Bjorn
    Hoffmann, Mikael
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (05) : 464 - 469
  • [44] Use of antipsychotic drugs and cholinesterase inhibitors and risk of falls and fractures: self-controlled case series
    Wang, Grace Hsin-Min
    Man, Kenneth K. C.
    Chang, Wei-Hung
    Liao, Tzu-Chi
    Lai, Edward Chia-Cheng
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [45] Incidence and Prevalence of Microscopic Colitis Between 2001 and 2016: A Danish Nationwide Cohort Study
    Weimers, Petra
    Ankersen, Dorit Vedel
    Lophaven, Soren
    Bonderup, Ole K.
    Munch, Andreas
    Lokkegaard, Ellen Christine Leth
    Burisch, Johan
    Munkholm, Pia
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (12) : 1717 - 1723
  • [46] The new Swedish Prescribed Drug Register -: Opportunities for pharmacoepidemiological research and experience from the first six months
    Wettermark, Bjorn
    Harnmar, Niklas
    MichaelFored, C.
    Leimanis, Andrejs
    Olausson, Petra Otterblad
    Bergman, Ulf
    Persson, Ingemar
    Sundstrom, Anders
    Westerholm, Barbro
    Rosen, Mans
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (07) : 726 - 735
  • [47] The varying effects of antibiotics on gut microbiota
    Yang, Lulu
    Bajinka, Ousman
    Jarju, Pa Omar
    Tan, Yurong
    Taal, Aji Mary
    Ozdemir, Guven
    [J]. AMB EXPRESS, 2021, 11 (01)
  • [48] Drug Exposure and Risk of Microscopic Colitis: A Systematic Review and Meta-Analysis
    Zhang, Shao-Wen
    Xu, Ru-hu
    Chen, Dan
    [J]. DIGESTIVE DISEASES, 2023, 41 (02) : 217 - 226
  • [49] Medication use and microscopic colitis: a multicentre retrospective cohort study
    Zylberberg, Haley M.
    Kamboj, Amrit K.
    De Cuir, Nicole
    Lane, Conor M.
    Khanna, Sahil
    Pardi, Darrell S.
    Lebwohl, Benjamin
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (11) : 1209 - 1215